Morte Beatriz, Manzano Jimena, Scanlan Thomas, Vennström Björn, Bernal Juan
Instituto de Investigaciones Biomédicas Alberto Sols, Consejo Superior de Investigaciones Cientificas-Universidad Autonoma de Madrid, Arturo Duperier 4, 28029 Madrid, Spain.
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3985-9. doi: 10.1073/pnas.062413299. Epub 2002 Mar 12.
Thyroid hormone (T3) controls critical aspects of cerebellar development, such as migration of postmitotic granule cells and terminal differentiation of Purkinje cells. T3 acts through nuclear receptors (TR) of two types, TRalpha1 and TRbeta, that either repress or activate gene expression. We have analyzed the cerebellar structure of developing mice lacking the TRalpha1 isoform, which normally accounts for about 80% of T3 receptors in the cerebellum. Contrary to what was expected, granule cell migration and Purkinje cell differentiation were normal in the mutant mice. Even more striking was the fact that when neonatal hypothyroidism was induced, no alterations in cerebellar structure were observed in the mutant mice, whereas the wild-type mice showed delayed granule cell migration and arrested Purkinje cell growth. The results support the idea that repression by the TRalpha1 aporeceptor, and not the lack of thyroid hormone, is responsible for the hypothyroid phenotype. This conclusion was supported by experiments with the TRbeta-selective compound GC-1. Treatment of hypothyroid animals with T3, which binds to TRalpha1 and TRbeta, prevents any defect in cerebellar structure. In contrast, treatment with GC-1, which binds to TRbeta but not TRalpha1, partially corrects Purkinje cell differentiation but has no effect on granule cell migration. Our data indicate that thyroid hormone has a permissive effect on cerebellar granule cell migration through derepression by the TRalpha1 isoform.
甲状腺激素(T3)控制着小脑发育的关键方面,例如有丝分裂后颗粒细胞的迁移以及浦肯野细胞的终末分化。T3通过两种类型的核受体(TR)起作用,即TRα1和TRβ,它们要么抑制要么激活基因表达。我们分析了缺乏TRα1亚型的发育中小鼠的小脑结构,该亚型通常占小脑中T3受体的约80%。与预期相反,突变小鼠中的颗粒细胞迁移和浦肯野细胞分化是正常的。更令人惊讶的是,当诱导新生小鼠甲状腺功能减退时,突变小鼠的小脑结构未观察到改变,而野生型小鼠则表现出颗粒细胞迁移延迟和浦肯野细胞生长停滞。这些结果支持了这样一种观点,即TRα1无活性受体的抑制作用而非甲状腺激素的缺乏导致了甲状腺功能减退的表型。TRβ选择性化合物GC-1的实验支持了这一结论。用与TRα1和TRβ结合的T3治疗甲状腺功能减退的动物,可防止小脑结构出现任何缺陷。相反,用与TRβ结合但不与TRα1结合的GC-1治疗,可部分纠正浦肯野细胞分化,但对颗粒细胞迁移没有影响。我们的数据表明,甲状腺激素通过TRα1亚型的去抑制作用对小脑颗粒细胞迁移具有允许作用。